Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06533176 · ClinicalTrials.gov registry record · NA

Real-time Personalized Brain State-dependent TMS After Stroke

A NA study of Stroke, sponsored by Sara Hussain.

Recruiting
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT06533176: Recruiting NA study of Stroke, sponsored by Sara Hussain.

NCT06533176 is a NA study of Stroke that is actively recruiting participants, run by Sara Hussain. The registered enrollment target is 37 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06533176, a NA study of Stroke, is actively recruiting participants, sponsored by Sara Hussain.

RECRUITING
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and enhance recovery of paretic upper extremity function after stroke. This project will test whether personalized brain state-dependent TMS can activate the residual corticospinal tract better than standard TMS, and evaluate the relationship between this activation and upper extremity motor impairment.

Conditions Studied

Interventions

  • DEVICE Personalized brain state-dependent single-pulse TMS

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2024-08-01
Est. Completion 2026-08
Phase NA

Sponsor

Sara Hussain

1 total trials

What the Registry Record Tells You About NCT06533176

The ClinicalTrials.gov registry entry for NCT06533176 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Sara Hussain, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Personalized brain state-dependent single-pulse TMS is the first listed.

NCT06533176 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT06533176 about?

NCT06533176 is a clinical study titled "Real-time Personalized Brain State-dependent TMS After Stroke". Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and enhance recovery of paretic upper extremity function after stroke. This project will test whether personalized brain state-dependent TMS can activate the residual cortic...

What is the current status of trial NCT06533176?

This trial is currently recruiting. It is a NA study. The enrollment target is 37 participants. The study started on 2024-08-01. Estimated completion is 2026-08.

What conditions does trial NCT06533176 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06533176?

The interventions under investigation include: Personalized brain state-dependent single-pulse TMS (DEVICE).

Who is sponsoring clinical trial NCT06533176?

This trial is sponsored by Sara Hussain, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06533176 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.